Progression-free rate as the principal end-point for phase II trials in soft-tissue sarcomas von Van Glabbeke, M, Verweij, J, Judson, I, Nielsen, O.S

Volltext

Phase II Study of ET-743 in Advanced Soft Tissue Sarcomas: A European Organisation for the Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group Trial von LE CESNE, A, BLAY, J. Y, COLLIN, F, JIMENO, J, DI PAOLA, E, VAN GLABBEKE, M, NIELSEN, O. S, JUDSON, I, VAN OOSTEROM, A, VERWEIJ, J, RADFORD, J, LORIGAN, P, RODENHUIS, S, RAY-COQUARD, I, BONVALOT, S

Volltext

Hypoxia in human soft tissue sarcomas : adverse impact on survival and no association with p53 mutations von NORDSMARK, M, ALSNER, J, KELLER, J, NIELSEN, O. S, JENSEN, O. M, HORSMAN, M. R, OVERGAARD, J

Volltext

Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft... von van Oosterom, A.T, Mouridsen, H.T, Nielsen, O.S, Dombernowsky, P, Krzemieniecki, K, Judson, I, Svancarova, L, Spooner, D, Hermans, C, Van Glabbeke, M, Verweij, J

Volltext

Advanced soft-tissue sarcoma: a disease that is potentially curable for a subset of patients treated with chemotherapy von Blay, J-Y, van Glabbeke, M, Verweij, J, van Oosterom, A.T, Le Cesne, A, Oosterhuis, J.W, Judson, I, Nielsen, O.S

Volltext

Gemcitabine in advanced adult soft-tissue sarcomas. A phase II study of the EORTC Soft Tissue and Bone Sarcoma Group von Švancárová, L, Blay, J.Y, Judson, I.R, van Hoesel, Q.G.C.M, van Oosterom, A.T, le Cesne, A, Keizer, H.J, Hermans, C, van Glabbeke, M, Verweij, J, Hogendoorn, P.C.W, Nielsen, O.S

Volltext

Effect of high-dose ifosfamide in advanced soft tissue sarcomas. A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma Group von Nielsen, O.S., Judson, I., van Hoesel, Q., le Cesne, A., Keizer, H.J., Blay, J.Y., van Oosterom, A., Radford, J.A., Svancárová, L., Krzemienlecki, K., Hermans, C., van Glabbeke, M., Oosterhuis, J.W., Verweij, J.

Volltext

Bone metastases: pathophysiology and management policy von NIELSEN, O. S, MUNRO, A. J, TANNOCK, I. F

Volltext

Exatecan in pretreated adult patients with advanced soft tissue sarcoma: Results of a phase II – Study of the EORTC Soft Tissue and Bone Sarcoma Group von Reichardt, P, Nielsen, O.S, Bauer, S, Hartmann, J.T, Schöffski, P, Christensen, T.B, Pink, D, Daugaard, S, Marreaud, S, Van Glabbeke, M, Blay, J.Y

Volltext

Prognostic factors in soft tissue sarcomas: The Aarhus experience von Vraa, S, Keller, J, Nielsen, O.S, Sneppen, O, Jurik, A.G, Jensen, O.M

Volltext

High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma group von NIELSEN, O. S, DOMBERNOWSKY, P, TURSZ, T, MOURIDSEN, H, CROWTHER, D, VERWEIJ, J, BUESA, J, STEWARD, W, DAUGAARD, S, VAN GLABBEKE, M, KIRKPATRICK, A

Volltext

Imatinib mesylate (STI-571 Glivec®, Gleevec™) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are unselecte... von Verweij, J, van Oosterom, A, Blay, J.-Y, Judson, I, Rodenhuis, S, van der Graaf, W, Radford, J, Le Cesne, A, Hogendoorn, P.C.W, di Paola, E.D, Brown, M, Nielsen, O.S

Volltext

Dose-response relationship of epirubicin in the treatment of postmenopausal patients with metastatic breast cancer: a randomized study of epirubicin at four different dose levels p... von BASTHOLT, L, DALMARK, M, JAKOBSEN, P, BENTZEN, S. M, GJEDDE, S. B, PFEIFFER, P, PEDERSEN, D, SANDBERG, E, KJAER, M, MOURIDSEN, H. T, ROSE, C, NIELSEN, O. S

Volltext

Coarse grain models and the computer simulation of soft materials von Nielsen, Steve O, Lopez, Carlos F, Srinivas, Goundla, Klein, Michael L

Volltext

Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment o... von Bellera, C.A., Penel, N., Ouali, M., Bonvalot, S., Casali, P.G., Nielsen, O.S., Delannes, M., Litière, S., Bonnetain, F., Dabakuyo, T.S., Benjamin, R.S., Blay, J.-Y., Bui, B.N., Collin, F., Delaney, T.F., Duffaud, F., Filleron, T., Fiore, M., Gelderblom, H., George, S., Grimer, R., Grosclaude, P., Gronchi, A., Haas, R., Hohenberger, P., Issels, R., Italiano, A., Jooste, V., Krarup-Hansen, A., Le Péchoux, C., Mussi, C., Oberlin, O., Patel, S., Piperno-Neumann, S., Raut, C., Ray-Coquard, I., Rutkowski, P., Schuetze, S., Sleijfer, S., Stoeckle, E., Van Glabbeke, M., Woll, P., Gourgou-Bourgade, S., Mathoulin-Pélissier, S.

Volltext

Elevated serum insulin-like growth factor-binding protein 2 (IGDBP-2) and decreased IGFBP-3 in epithelial ovarian cancer : Correlation with cancer antigen 125 and tumor-associated... von FLYVBJERG, A, MOGENSEN, O, MOGENSEN, B, NIELSEN, O. S

Volltext

Phase 1 European Organisation for Research and Treatment of Cancer study determining safety of pegylated liposomal doxorubicin (Caelyx®) in combination with ifosfamide in previousl... von Nielsen, O.S., Reichardt, P., Christensen, T.B., Pink, D., Daugaard, S., Hermans, C., Marreaud, S., van Glabbeke, M., Blay, J., Judson, I.

Volltext

The relationship between tumor oxygenation and cell proliferation in human soft tissue sarcomas von Nordsmark, Marianne, Høyer, Morten, Keller, Johnny, Nielsen, Ole Steen, Jensen, Oluf Myhre, Overgaard, Jens

Volltext

Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study von van Oosterom, Allan T, Judson, Ian, Verweij, Jaap, Stroobants, Sigrid, di Paola, Eugenio Donato, Dimitrijevic, Sasa, Martens, Marc, Webb, Andrew, Sciot, Raf, Van Glabbeke, Martine, Silberman, Sandra, Nielsen, Ole S

Volltext

Temozolomide in adult patients with advanced soft tissue sarcoma: a phase II study of the EORTC Soft Tissue and Bone Sarcoma Group von Woll, P.J, Judson, I, Lee, S.M, Rodenhuis, S, Nielsen, O.S, Buesa, J.M, Lorigan, P.C, Leyvraz, S, Hermans, C, van Glabbeke, M, Verweij, J

Volltext